Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread into more than 200 countries …

Mesenchymal stem cells (MSCs) are multipotent stem cells. In addition to the capacity for
self-renewal and multipotential differentiation, MSCs also have the following characteristics …

Patients with severe COVID-19 experience cytokine storm, an uncontrolled upregulation of
pro-inflammatory cytokines, which if unresolved leads to acute respiratory distress syndrome …

Mesenchymal stem cells (MSCs) are attractive in various fields of regenerative medicine due
to their therapeutic potential and complex unique properties. Basic stem cell research and …

Currently, there are no specific and efficient vaccines or drugs for COVID-19, particularly in
severe cases. A wide range of variations in the clinical symptoms of different patients …

Pulmonary fibrosis (PF) is a chronic, progressive, fibrotic interstitial disease of the lung with
poor prognosis and without effective treatment currently. Data from previous coronavirus …

Transplantation of umbilical cord blood (UCB) is an attractive alternative source of
hematopoietic stem cells (HSCs). The unique properties of cord blood and its distinct …

Background Senescent adipose-derived stem cells (ASCs) exhibit reduced therapeutic
efficacy during wound healing. Transcriptional regulation factors including long noncoding …

Insights into the use of cellular therapeutics, extracellular vesicles (EVs), and tissue
engineering strategies for regenerative medicine applications are continually emerging with …

Mesenchymal stem cells (MSCs) have shown promising ability to treat critical cases of
coronavirus disease 2019 (COVID-19) by regenerating lung cells and reducing immune …